Related Experiment Video
Updated: Aug 24, 2026

Repressing Gene Transcription by Redirecting Cellular Machinery with Chemical Epigenetic Modifiers
Published on: September 20, 2018
Promoter methylation inhibits APC gene expression by causing changes in chromatin conformation and interfering with
Guoren Deng1, Geun-Am Song, Erik Pong
1Gastrointestinal Research Laboratory, Veteran Affairs Medical Center and Department of Medicine, University of California San Francisco, San Francisco, California, USA.
Abstract:
As an important regulator in Wnt-signaling pathway, the APC gene is involved in apoptosis and cell cycle arrest. The loss of APC function is observed in most familial adenomatous polyposis-associated and sporadic colorectal cancer. APC gene is frequently inactivated by DNA mutations. However, hypermethylation in APC gene promoter was also observed in different cancers. In this study, by analyzing the methylation status of APC promoter in 22 colorectal cancer cell lines with different APC expression levels, we identified Regions A and B in the promoter, where the methylation of CpG sites was invariably correlated with the loss of gene expression. By nuclease accessibility assay, we also observed a correlation between the closed chromatin conformation in APC promoter and loss of gene expression. When the nonexpressing cell lines were treated with a DNA methyltransferase inhibitor, 5-Aza-2'-Deoxycytidine, the APC expression in these cells was induced, CpG sites were demethylated, and closed chromatin conformation was opened. However, when these cell lines were treated with a histone deacetylase inhibitor, Trichostatin A, no significant changes in APC expression, methylation status, and chromatin conformation were observed. Using transient transfection assay, a CCAAT box located in Region B was identified, which was involved in up-regulation of APC expression. Methylation of CpG sites around the CCAAT box resulted in a significant inhibition in the gene expression. The specific binding of a transcription factor CCAAT-binding factor (CBF) to the CCAAT box was determined by electrophoretic mobility shift analysis. The binding was inhibited after CpG sites close to the CCAAT box were methylated, indicating that DNA methylation can silence gene expression through interfering with the binding of transcription factors to the promoter. The biological function of CBF in APC gene regulation was further indicated by the decrease of luciferase activities in cells cotransfected with a plasmid carrying APC promoter/luciferase gene and a plasmid expressing dominant negative CBF mutant. In summary, methylation of CpG sites around CCAAT box in APC promoter inhibits the gene expression by changing the chromatin conformation and interfering with the binding of transcription factor CBF to CCAAT box.
Insights
DNA methylation silences the APC gene in colorectal cancer by altering chromatin structure and blocking transcription factor binding. This epigenetic silencing is reversible with demethylating agents.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Biology
Background:
- The Adenomatous Polyposis Coli (APC) gene is a key regulator of the Wnt-signaling pathway, crucial for apoptosis and cell cycle control.
- Loss of APC function, often due to DNA mutations, is implicated in colorectal cancer development.
- Epigenetic modifications, such as promoter hypermethylation, can also lead to APC gene silencing in various cancers.
Purpose of the Study:
- To investigate the role of APC promoter methylation in colorectal cancer cell lines.
- To identify specific regulatory regions within the APC promoter affected by methylation.
- To elucidate the molecular mechanisms by which APC gene expression is silenced.
Main Methods:
- Analysis of APC promoter methylation status and gene expression in 22 colorectal cancer cell lines.
- Nuclease accessibility assays to assess chromatin conformation.
- Treatment with DNA methyltransferase inhibitor (5-Aza-2'-Deoxycytidine) and histone deacetylase inhibitor (Trichostatin A).
- Transient transfection assays, electrophoretic mobility shift assays (EMSA), and luciferase reporter assays to study transcription factor binding and gene regulation.
Main Results:
- Identified Regions A and B in the APC promoter where CpG site methylation correlated with loss of gene expression.
- Demonstrated that 5-Aza-2'-Deoxycytidine treatment induced APC expression, demethylated CpG sites, and opened chromatin.
- Showed that methylation around a CCAAT box in Region B inhibited APC expression by preventing CCAAT-binding factor (CBF) binding, confirmed by EMSA and luciferase assays.
Conclusions:
- APC gene silencing in colorectal cancer is mediated by DNA methylation of CpG sites within the promoter, particularly around the CCAAT box.
- This methylation alters chromatin conformation and interferes with the binding of transcription factor CBF, leading to gene silencing.
- The findings highlight the epigenetic regulation of APC and its potential as a therapeutic target.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Anaphase Promoting Complex
Abnormal Proliferation
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...

